Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,035	919.53	1,048	483.43	617.58	1,075
Short-Term Investments	74.57	-	275.79	110.09	-	-
Trading Asset Securities	596.23	1,723	2,080	2,814	2,806	2,300
Cash & Short-Term Investments	1,706	2,643	3,404	3,407	3,424	3,375
Cash Growth	-38.07%	-22.36%	-0.09%	-0.49%	1.46%	70.44%
Accounts Receivable	1,026	957.49	631.78	479.97	276.1	218.35
Other Receivables	220.19	147.98	80.66	42.83	12.69	2.77
Receivables	1,246	1,105	712.44	522.79	288.79	221.13
Inventory	1,067	1,198	916.79	839.33	645.38	459.29
Prepaid Expenses	4.2	23.72	7.44	32.29	104.75	48.32
Other Current Assets	91.32	85.75	23.09	20.8	34.16	21.48
Total Current Assets	4,115	5,056	5,064	4,822	4,497	4,125
Property, Plant & Equipment	1,748	1,694	1,442	1,325	1,134	803.51
Long-Term Investments	2,206	1,926	924.95	357.62	136.9	-
Other Intangible Assets	243.81	245.06	169.46	172.48	94.56	98.91
Long-Term Accounts Receivable	340.99	310.8	189.17	93.85	28.1	-
Long-Term Deferred Tax Assets	76.47	63.98	37.94	22.9	12.14	22.73
Long-Term Deferred Charges	140.15	150.83	156.69	69.08	74.97	77.56
Other Long-Term Assets	113.64	173.35	238.22	150.77	157.39	178.06
Total Assets	8,984	9,619	8,222	7,015	6,136	5,306
Accounts Payable	177.01	456.62	126.99	176.68	171.35	98.26
Accrued Expenses	172.5	200.59	187.77	149.03	124.27	121.78
Current Portion of Leases	1.59	1.34	1.69	1.32	1.35	-
Current Income Taxes Payable	68.27	120.14	120.35	76.19	59.92	95.9
Current Unearned Revenue	61.05	80.13	91.48	108.94	77.08	71.06
Other Current Liabilities	49.95	49.91	63.2	71.78	73.96	105.74
Total Current Liabilities	530.37	908.74	591.48	583.94	507.94	492.74
Long-Term Leases	2.37	2.76	3.49	0.89	0.88	-
Long-Term Unearned Revenue	43.68	47.26	33.06	5.81	6.58	8.74
Long-Term Deferred Tax Liabilities	90.05	78.51	50.06	24.41	8.11	-
Other Long-Term Liabilities	6.16	5.58	-	-	-	-
Total Liabilities	672.63	1,043	678.09	615.06	523.51	501.49
Common Stock	785.72	785.72	785.72	786.13	786.66	412.35
Additional Paid-In Capital	1,332	1,332	1,332	1,348	1,450	1,601
Retained Earnings	6,166	6,417	5,374	4,267	3,411	2,850
Treasury Stock	-	-	-	-16.29	-37.51	-58.55
Comprehensive Income & Other	26.47	41.72	52.7	13.99	1.64	-0.33
Shareholders' Equity	8,311	8,577	7,544	6,399	5,612	4,804
Total Liabilities & Equity	8,984	9,619	8,222	7,015	6,136	5,306
Total Debt	3.96	4.1	5.18	2.22	2.24	-
Net Cash (Debt)	1,702	2,639	3,399	3,405	3,422	3,375
Net Cash Growth	-38.11%	-22.36%	-0.17%	-0.49%	1.40%	70.44%
Net Cash Per Share	2.17	3.36	4.33	4.33	4.35	4.50
Filing Date Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Total Common Shares Outstanding	785.72	785.72	785.72	786.13	786.66	783.47
Working Capital	3,584	4,147	4,473	4,238	3,989	3,632
Book Value Per Share	10.58	10.92	9.60	8.14	7.13	6.13
Tangible Book Value	8,067	8,332	7,375	6,227	5,517	4,705
Tangible Book Value Per Share	10.27	10.60	9.39	7.92	7.01	6.01
Buildings	1,061	1,061	1,061	541.55	516.8	504.42
Machinery	858.93	811.8	659.08	512.48	427.32	313.43
Construction In Progress	488.92	414.56	169.32	605.7	442.99	172.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.